- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Ceres Nanosciences, LLLP, a biotechnology company using its proprietary Nanotrap™ capture particle technology to develop diagnostics and research products, announced today that it has launched the first release of Nanotrap™ ESP Particles designed to improve complex biofluid sample processing allowing for the detection of low-abundance proteins that would not otherwise be detected.
The Nanotrap™ ESP product targets end users working with a variety of sample types that require a more efficient and powerful method of sample preparation for downstream detection and analysis.
Nanotrap™ ESP Particles improve the sensitivity of any gel electrophoresis protein detection method including silver staining, Coomassie Blue, Western Blotting and mass spectroscopy analysis.
The ability to rapidly harvest multiple proteins and peptides from a single sample makes Nanotrap™ ESP particles an ideal tool for researchers interested in rapid sample processing of low abundance proteins or for the discovery of unknown proteins and peptides present in samples containing high-abundance interfering proteins.
The use of this technology for these applications has recently been published by Dr. Lance Liotta and Dr. Emanuel Petricoin in the journals Nano Research and Nano Letters in 2008 and 2009. "Currently, the single largest barrier to biomarker measurement is the inherent lack of sensitivity of most proteomics platforms" said Emanuel Petricoin, Ph. D., co-director of the Center for Applied Proteomics and Molecular Medicine at George Mason University. "The Nanotrap ESP technology provides a powerful new sample preparation approach that tremendously increases the concentration of the biomarker, and greatly aids our own disease biomarker research."
About Ceres Nanosciences
Ceres Nanosciences, LLLP is a privately held company focused on the development of diagnostic products using its unique and proprietary Nanotrap™ capture particle technology. Ceres’ business goals are to develop a number of commercial applications of the Nanotrap™ for high-demand diagnostics and other needs in the life science industry.
For more information, please click here
Copyright © Ceres NanosciencesIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Kalam: versatility personified August 1st, 2015
Aculon Launches NanoProof Series for PCB Waterproofing July 20th, 2015
Dais Analytic Unveils New Version of Aqualyte Membrane Technology: Updates to the Basis of the Company's Industry-Changing Nanotechnology Designed to Strengthen Position in Global Air, Energy, and Water Markets June 26th, 2015
Self-assembling, biomimetic membranes may aid water filtration August 1st, 2015
European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award: The Award to be presented at BIO-Europe conference in Munich, November 2015 July 30th, 2015
New computer model could explain how simple molecules took first step toward life: Two Brookhaven researchers developed theoretical model to explain the origins of self-replicating molecules July 28th, 2015
Spintronics: Molecules stabilizing magnetism: Organic molecules fixing the magnetic orientation of a cobalt surface/ building block for a compact and low-cost storage technology/ publication in Nature Materials July 25th, 2015